Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...
Hosted on MSN23h
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call TranscriptWe initiated our '24-'25 COVID-19 commercial season in mid-September shortly after achieving ... including both KP.3.1.1 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback